IRIS
GIUNTI, DEBORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.483
Totale 3.483
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 3.483
Totale 3.483
Salva come PNG Salva come JPEG
Città #
Genova 2.227
Genoa 455
Rapallo 451
Vado Ligure 336
Bordighera 14
Totale 3.483
Salva come PNG Salva come JPEG
Nome #
Neuroprotective features of mesenchymal stem cells. 178
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. 158
Mechanisms of the adaptive immune response inside the central nervous system during inflammatory and autoimmune diseases. 157
Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis. 153
Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. 147
Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis. 140
A major influence of the T cell receptor repertoire as compared to antigen processing-presentation in the selection of myelin basic protein epitopes in multiple sclerosis. 134
A restricted T cell response to myelin basic protein (MBP) is stable in multiple sclerosis (MS) patients. 133
Mesenchymal stem cells shape microglia effector functions through the release of CX3CL1 130
Central and peripheral nervous system complications following allogeneic bone marrow transplantation. 122
Myelin basic protein intramolecular spreading without disease progression in a patient with multiple sclerosis. 120
Demyelination and axonal damage in a non-human primate model of multiple sclerosis. 115
Characterization of the response to myelin basic protein in a non human primate model for multiple sclerosis. 113
Human mesenchymal stem cells modulate B-cell functions. 111
Analisi e studio longitudinale della fine specificità di linee linfocitarie T specifiche per la proteina basica della mielina (MBP) in pazienti con sclerosi multipla e in controlli normali. 107
Restricted immune responses lead to CNS demyelination and axonal damage. 103
Mesenchymal stem cells exert anti-oxidant effects through the impairment of arginine metabolism 97
Intravenous Mesenchymal Stem Cells Improve Survival and Motor Function in Experimental Amyotrophic Lateral Sclerosis 97
Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS. 94
Dynamics of the reactivity to MBP in multiple sclerosis. 93
racterization of the response to myelin basic protein in a non human primate model for multiple sclerosis. 91
Characterization of the TCRB chain repertoire in the New World monkey Callithrix jacchus. 89
Effect of miRNAs shuttled by exosomes derived from primed-MSCs on activated-microglia phenotype and possible implication in amyotrophic lateral sclerosis. 87
miRNAs shuttled by exosomes derived from primed-MSCs affect the activated-microglia phenotype and possibly support the therapeutic effects of MSC administration in SOD1G93A mice 83
Mesenchymal stem cells exert anti-oxidant effects through the impairment of arginine metabolism 74
Exosome-shuttled miRNAs derived from mesenchymal stem cells modulate in-vitro the reactive phenotype of amyotrophic lateral sclerosis glial cells 73
Mesenchimal stem cells exert beneficial effects on microglia 73
Exosome-shuttled miRNAs derived from mesenchymal stem cells modulate in-vitro the reactive phenotype of amyotrophic lateral sclerosis glial cell 72
Role of miRNAs shuttled by mesenchymal stem cell-derived small extracellular vesicles in modulating neuroinflammation 68
Mesenchymal stem cells exert their therapeutic effect by inducing microglia to acquire a neuroprotective phenotype 61
MRI and neuropathologic study of eae in the non human primate callithr1x jacchus 48
Micro-RNAs Shuttled by Extracellular Vesicles Secreted from Mesenchymal Stem Cells Dampen Astrocyte Pathological Activation and Support Neuroprotection in In-Vitro Models of ALS 39
microRNAs shuttled by extracellular vesicles derived from mesenchymal stem cells rescue glial activation in in-vitro models of amyotrophic lateral sclerosis 31
Therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 29
In-vivo therapeutic effects of extracellular vesicles derived from mesenchymal stem after systemic administration on ALS mice 24
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 23
COVID-19-associated serum and cerebrospinal fluid cytokines in post- versus para-infectious SARS-CoV-2-related Guillain–Barré syndrome 15
MSC-derived extracellular vesicles for the treatment of ALS 14
In-vitro and in-vivo studies showing the beneficial effects of extracellular vesicles derived from mesenchymal stem cells on the reactive astrocyte activation in amyotrophic lateral sclerosis 11
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 11
microRNAs shuttled by extracellular vesicles derived from mesenchymal stem cells revert glial activation and neurotoxicity in in-vitro models of amyotrophic lateral sclerosis 9
null 1
Totale 3.528
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.288
article - articoli 8.375
book - libri 0
conference - conferenze 2.913
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.576
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020616 0 0 0 0 0 82 151 47 80 132 86 38
2020/2021212 17 15 23 24 12 8 14 30 20 20 15 14
2021/2022419 15 47 34 59 17 15 15 88 15 34 7 73
2022/2023521 42 51 4 50 104 73 4 30 86 7 63 7
2023/2024365 10 22 14 40 45 89 19 31 10 9 20 56
2024/2025383 61 53 25 73 89 82 0 0 0 0 0 0
Totale 3.528